Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06330649 · ClinicalTrials.gov registry record · NA
The Acute Effect of and Energy Drink vs. Water Consumption on MAP, HR, and Energy Metabolism
A NA study, sponsored by The University of Texas at Arlington.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT06330649: Completed NA study, sponsored by The University of Texas at Arlington.
NCT06330649 is a NA study that has completed, run by The University of Texas at Arlington. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06330649, a NA study, has completed, sponsored by The University of Texas at Arlington.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The objective of this protocol is to investigate the effect of consumption of a commercially available energy drink beverage on blood pressure, heart rate, and energy metabolism
Primary Outcome
blood pressure will be measured on the upper arm using standard procedures that are done in a doctors office.
Interventions
- OTHER Water Control
- DIETARY_SUPPLEMENT Energy Drink
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2024-01-01 |
| Est. Completion | 2024-09-01 |
| Phase | NA |
What the finished NCT06330649 record still lists
NCT06330649 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Water Control is the first listed.
NCT06330649 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06330649 about?
NCT06330649 is a clinical study titled "The Acute Effect of and Energy Drink vs. Water Consumption on MAP, HR, and Energy Metabolism". The objective of this protocol is to investigate the effect of consumption of a commercially available energy drink beverage on blood pressure, heart rate, and energy metabolism
What is the current status of trial NCT06330649?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2024-01-01. Estimated completion is 2024-09-01.
What interventions are being tested in trial NCT06330649?
The interventions under investigation include: Water Control (OTHER), Energy Drink (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06330649?
This trial is sponsored by The University of Texas at Arlington, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06330649's enrollment target sits among peer trials
32 1578th of 2000 higher than 409 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI